RNA, U2 small nuclear 38, pseudogene (RNU2-38P)

RNU2-38P is a member of the U2 small nuclear RNA pseudogene family. The canonical U2 snRNA is an essential component of the major spliceosome complex, playing a critical role in the recognition of the branch site during pre-mRNA splicing[1][2]. However, RNU2-38P, as denoted by the “pseudogene” designation, represents a nonfunctional, noncoding locus that does not produce a functional small RNA. True or functional U2 snRNAs (e.g., RNU2-1, RNU2-2) participate directly in the splicing process and, when mutated, are implicated in inherited disease and some cancers[2]. Pseudogenes such as RNU2-38P do not encode for active RNAs and are not incorporated into the spliceosome complex. As such, they lack biological function, are not disease-associated targets, and have no known role in therapeutics, drug interactions, or biomarker development. Additional context: Active U2 snRNA genes (such as RNU2-1, RNU2-2) are critical for mRNA processing and mutations in those can result in severe neurodevelopmental syndromes or contribute to oncogenesis[2]. However, pseudogenes like RNU2-38P are genomic relics, often arising through gene duplication or retrotransposition, but they are typically transcriptionally inactive and lack conserved function. No evidence is present in the scientific literature for a functional, disease, or pharmacological role for RNU2-38P. Summary: RNU2-38P is a nonfunctional pseudogene; it is not a receptor, enzyme, transporter, or drug discovery target, and does not possess known biological or disease relevance[2]. If you seek a spliceosomal snRNA with functional or clinical importance, RNU2-1 (“RNA, U2 small nuclear 1”), or RNU2-2 (“RNA, U2 small nuclear 2”) should be considered instead[2].

Other names

U2 snRNA pseudogene 38RNU2-38P